You are here

Article Text

Article menu
Download PDFPDF
Letter
Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20

https://doi.org/10.1136/annrheumdis-2019-215918

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors Conceptualisation: DMS and AKO. Methodology: DMS and AKO. Investigation: DMS, SB, NS-M, AB, SR, DS, PH, TR, AJ, IA and KSB. Formal analysis: DMS and SB. Writing: DMS, SB and AKO. Supervision: DLK, JDM and AKO.

    • Funding This study was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute for Allergy and Infectious Diseases, the National Institute for Arthritis and Musculoskeletal and Skin Diseases, and the NIH Transitional Program for Clinical Research.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Ethics approval NIH Institutional Review Board, 94-HG-0105, IRB00000006.

    • Provenance and peer review Not commissioned; externally peer reviewed.